fatty-liver

Documents about fatty-liver

• Hydrogen-rich Water for Non-alchoholic Fatty Liver Disease#856958ClinicalTrials.gov
• Relationship Between Heart Failure With Preserved Ejection Fraction and Nonalcoholic Fatty Liver Disease.#879935ClinicalTrials.gov
• Role of Pioglitazone and Berberine in Treatment of Non-Alcoholic Fatty Liver Disease#892924ClinicalTrials.gov
• Effects of Exercise on Patients With Nonalcoholic Fatty Liver Disease- A Comparative Randomized Controlled Trial#980118ClinicalTrials.gov
• A Study of LY3885125 in Participants With Dyslipidemia or Non-Alcoholic Fatty Liver Disease (NAFLD)#834756ClinicalTrials.gov
• Clinical Course and Biomarkers Associated With Nonalcoholic Fatty Liver Disease (NAFLD) in Chinese Patients With Obesity#841464ClinicalTrials.gov
• Combination Obeticholic Acid (OCA) and Statins for Monitoring of Lipids (CONTROL)#848531ClinicalTrials.gov
• Cognitive Assessment and Brain Function Evaluation in Patients With Non-alcoholic Fatty Liver Disease#856858ClinicalTrials.gov
• Chia Supplementation and Non Alcoholic Fatty Liver Disease#875316ClinicalTrials.gov
• Non-alcoholic Fatty Liver Disease in Women With Polycystic Ovary Syndrome#912852ClinicalTrials.gov
• Noncoding RNAs as additional mediators of epigenetic regulation in nonalcoholic fatty liver disease#983818HAL (France)
• Clinical Characteristics of Metabolic Associated Fatty Liver Disease#992466ClinicalTrials.gov
• Long-term Investigation of Resveratrol on Fat Metabolism in Obese Men With Nonalcoholic Fatty Liver Disease#829299ClinicalTrials.gov
• Nonalcoholic Fatty Liver Disease (NAFLD) Database 3#474861ClinicalTrials.gov
• Adding Exenatide to Insulin Therapy for Patients With Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease#18805ClinicalTrials.gov
• Comparative Study Between Obeticholic Acid Versus Vitamin E in Patients with Non-alcoholic Steatohepatitis#993279ClinicalTrials.gov
• Fatty Acids Lipidome and Oxidative Stress in Liver Transplantation#892531ClinicalTrials.gov
• Nonalcoholic Fatty Liver Disease (NAFLD) Adult Database 2#181686ClinicalTrials.gov
• Transforming Non-Invasive Liver Disease Detection by MRE: The Hepatogram#863577ClinicalTrials.gov
• Combination Diagnostic Strategies in NAFLD#881643ClinicalTrials.gov
• Pharmacoeconomic Evaluation of the Cost/effectiveness Ratio of Physical Exercise on Non-alcoholic Fatty Liver Disease#303653ClinicalTrials.gov
• Non-Alcoholic Fatty Liver Disease, Diet and Contributing Factors: A Narrative Literature Review#434869Scholars Crossing
• Saroglitazar Magnesium 4 mg for Nonalcoholic Fatty Liver Disease (NAFLD) in People Living With HIV in the US#831218ClinicalTrials.gov
• Safety and Efficacy Study of IMM 124-E (Bovine Colostrum) for Patients With Nonalcoholic Steatohepatitis#877613ClinicalTrials.gov
• Safety and Efficacy of Hoodia Gordonii for Treatment of Non Alcoholic Fatty Liver Disease (NAFLD)#918942ClinicalTrials.gov
• Novel MRE Technique to Assess a Risk Factor for Liver Cancer#888626ClinicalTrials.gov
• Burden of metabolic dysfunction-associated steatotic liver disease in the Asia-Pacific region from 1990 to 2023#305634Recep Tayyip Erdoğan University Institutional Repository
• Comparative Clinical Study to Evaluate the Efficacy and Safety of Rosuvastatin Vs CoQ10 on Nonalcoholic Steatohepatitis#895447ClinicalTrials.gov
• Fighting Fatty Liver in India#894028ClinicalTrials.gov
• Metabolic Associated Fatty Liver Disease and Pancreatic Steatosis in Obese Versus Lean Chronic Hepatitis B Patients#230321ClinicalTrials.gov
• A Pathophysiological Study of the Postprandial Human Liver (PLS)#865242ClinicalTrials.gov
• Effect of Iron Depletion by Phlebotomy Plus Lifestyle Changes vs. Lifestyle Changes Alone on Liver Damage in Patients With Nonalcoholic Fatty Liver Disease With Increased Iron Stores#451444ClinicalTrials.gov
• Endoscopic Ultrasound Shear Wave for Liver Fibrosis in MASLD Patients: The RUMIPAMBA Trial#829680ClinicalTrials.gov
• MRI to Measure Liver Fat Content#853432ClinicalTrials.gov
• Transient Elastograghy to Detect Non Alcoholic Fatty Liver Disease in Renal Transplantation Recipients.#813152ClinicalTrials.gov
• Intermittent Fasting Versus Diet to Stop Hypertension on Metabolic Risk Profile in Nonalcoholic Fatty Liver Patients#875235ClinicalTrials.gov
• Effect of Vitamin A and Calcium in Patients With Non-alcoholic Fatty Liver Disease#1007596ClinicalTrials.gov
• The Study of Multiple Doses of CM-101 in Male and Female NAFLD (Nonalcoholic Fatty Liver Disease) and NAFLD/NASH (Nonalcoholic Steatohepatitis) Subjects#1030936ClinicalTrials.gov
• Phase 2b Study in NASH to Assess IVA337#800944ClinicalTrials.gov
• Ultrasound Liver Fat Quantification on Pediatric Patients#879504ClinicalTrials.gov
• Liver Cirrhosis Diagnosis Prioritizing Algorithm Based on Electronic Health Records.#878760ClinicalTrials.gov
• The Effect of a Probiotic on Hepatic Steatosis#152606ClinicalTrials.gov
• NAC- NAFLD And Cushing#442006ClinicalTrials.gov
• Nonalcoholic fatty liver disease as a metabolic disease in humans: A literature review#268638HAL (France)
• A Longitudinal Observational Study of Patients With Nonalcoholic Steatohepatitis (NASH) and Related Conditions Across the Entire Spectrum of Nonalcoholic Fatty Liver Disease (NAFLD)#850201ClinicalTrials.gov
• The Influence of SARS-CoV-2 Lifestyle Changes on Non-alcoholic Fatty Liver Disease Evolution#861558ClinicalTrials.gov
• Protective effects of vitamin C and E supplementation against alcoholic fatty liver in Mus musculus (Albino mice)#977988Animo Repository
• The Effect of Soy Isoflavones on Non-alcoholic Fatty Liver Disease and the Level of FGF-21 and Fetuin A#862692ClinicalTrials.gov
• Screening of Liver Fibrosis in Adults Without Known Liver Disease#1007396ClinicalTrials.gov
• A Bidirectional Study in Exploring the Dynamic Changes of Plasma and Urine Metabolites of Liver Cancer#904538ClinicalTrials.gov